Advertisement
Advertisement
Xalatan

Xalatan

latanoprost

Manufacturer:

Viatris

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Latanoprost
Indications/Uses
Reduction of elevated IOP in patients w/ open-angle & chronic angle-closure glaucoma & ocular HTN.
Dosage/Direction for Use
Adult including elderly 1 drop in affected eye(s) once daily in evening.
Contraindications
Special Precautions
Avoid use in active herpes simplex keratitis & history of recurrent herpetic keratitis. Increased iris pigmentation; eyelid & eyelash changes. Aphakic & pseudophakic patients w/ torn posterior lens cap or known risk factors for macular edema; inflammatory neovascular glaucoma. Remove contact lens prior to administration & reinsert after 15 min. Administer at least 5 min apart if >1 topical ophth drug is being used. May affect ability to drive & use machines. Pregnancy & lactation. Paed <1 yr & preterm infants <36 wk gestation. Childn <3 yr w/ primary congenital glaucoma.
Adverse Reactions
Herpetic keratitis; dizziness, headache; eye irritation & pain, eyelash & eyelid vellus hair changes, ocular hyperaemia, iris hyperpigmentation, blepharitis, conjunctivitis, macular edema, photophobia, eyelid oedema, keratitis, uveitis, corneal oedema & erosions, iritis, punctate keratitis, trichiasis, blurred vision, periorbital & lid changes, darkening of eyelid palpebral skin, localised eyelid skin reaction, iris cyst, ocular conjunctiva pseudopemphigoid; angina, palpitations, unstable angina; asthma, dyspnoea, asthma aggravation, acute asthma attacks; vomiting, nausea; rash, pruritus; myalgia, arthralgia; chest pain.
Drug Interactions
Paradoxical IOP elevations w/ concomitant use of ≥2 other prostaglandins, prostaglandin analogs or derivatives.
MIMS Class
Antiglaucoma Preparations
ATC Classification
S01EE01 - latanoprost ; Belongs to the class of prostaglandin analogues. Used in the treatment of glaucoma.
Presentation/Packing
Form
Xalatan eye drops 50 mcg/mL
Packing/Price
2.5 mL x 1's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement